StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cardiol Therapeutics's enterprise value was $72.68M on Nov 11, 2026, against $53.26M a year earlier. Over the last 5 years it ranged from -$39.96M to $156.35M, with a median of $53.26M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$72.68M+58.1%
2025Dec 31, 2025$45.96M-21.1%
2024Dec 31, 2024$58.25M+660.6%
2023Dec 29, 2023$7.66M–
2022Dec 30, 2022-$39.96M-190.3%
2021Dec 31, 2021$44.26M–

More Cardiol Therapeutics figures

See a number that looks wrong?